1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aldeyra Therapeutics Inc (ALDX)
  7. News

ALDX

Aldeyra Therapeutics Inc
8.925
0.865 (10.73%)
Upgrade to Real-Time
Stock Name Stock Symbol Market Stock Type
Aldeyra Therapeutics Inc ALDX NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
Upgrade Icon
0.865 10.73% 8.925 01:29:58
Open Price Low Price High Price Close Price Previous Close
8.30 8.30 8.9669 8.06
more quote information »

Recent News

Date Time Source Heading
16/3/202322:00BWAldeyra Therapeutics Announces Completion of Enrollment in..
11/3/202308:53EDGARCurrent Report Filing (8-k)
10/3/202308:20EDGARSecurities Registration: Employee Benefit Plan (s-8)
10/3/202308:04EDGARAnnual Report (10-k)
09/3/202323:08EDGARCurrent Report Filing (8-k)
09/3/202323:00BWAldeyra Therapeutics Reports Full-Year 2022 Financial..
03/3/202308:26EDGARStatement of Changes in Beneficial Ownership (4)
03/3/202308:23EDGARStatement of Changes in Beneficial Ownership (4)
02/3/202323:06EDGARCurrent Report Filing (8-k)
02/3/202323:00BWFDA Accepts for Priority Review ADX-2191 New Drug..
01/3/202323:00BWAldeyra Therapeutics Schedules Webcast and Conference Call..
28/2/202323:00BWAldeyra Therapeutics Announces Positive Top-Line Results..
23/2/202323:00BWAldeyra Therapeutics Announces Next-Generation..
16/2/202323:00BWAldeyra Therapeutics Advances Investigational Oral RASP..
15/2/202306:34EDGARAmended Statement of Ownership (sc 13g/a)
09/2/202323:00BWAldeyra Therapeutics to Participate in Fireside Chat at the..
07/2/202323:06EDGARCurrent Report Filing (8-k)
07/2/202323:00BWAldeyra Therapeutics Announces FDA Acceptance of New Drug..
04/2/202303:26EDGARAmended Statement of Ownership (sc 13g/a)
27/12/202223:01EDGARCurrent Report Filing (8-k)
21/12/202223:06EDGARCurrent Report Filing (8-k)
21/12/202223:00BWAldeyra Therapeutics Submits New Drug Application to the..
14/12/202200:00BWAldeyra Therapeutics’ Investigational RASP Modulator ADX-629..
02/12/202200:06EDGARCurrent Report Filing (8-k)
02/12/202200:00BWAldeyra Therapeutics Announces Positive Primary..
30/11/202200:00BWAldeyra Therapeutics Submits New Drug Application to the..
14/11/202214:57TRMNAldeyra Therapeutics (ALDX) Receives a Buy from SVB..
11/11/202222:25TRMNH.C. Wainwright Sticks to Their Buy Rating for Aldeyra..
11/11/202208:06EDGARQuarterly Report (10-q)
10/11/202223:07EDGARCurrent Report Filing (8-k)
10/11/202223:00BWAldeyra Therapeutics Reports Third-Quarter 2022 Financial..
03/11/202223:00BWAldeyra Therapeutics Schedules Webcast and Conference Call..
26/10/202223:00BWAldeyra Therapeutics Announces Oral Presentation of Phase 3..
11/10/202219:15TRMNH.C. Wainwright Reaffirms Their Buy Rating on Aldeyra..
06/10/202222:06EDGARCurrent Report Filing (8-k)
06/10/202222:00BWAldeyra Therapeutics Achieves Primary Endpoint in Part 1 of..
06/10/202207:05BWAldeyra Therapeutics Schedules Conference Call and Webcast..
14/9/202222:07EDGARCurrent Report Filing (8-k)
14/9/202222:00BWAldeyra Therapeutics Announces Positive Dry Eye Disease..
07/9/202222:00BWAldeyra Therapeutics to Participate in Upcoming Investor..
12/8/202206:10EDGARStatement of Changes in Beneficial Ownership (4)
10/8/202206:10EDGARStatement of Changes in Beneficial Ownership (4)
09/8/202206:10EDGARStatement of Changes in Beneficial Ownership (4)
08/8/202220:26TRMNH.C. Wainwright Sticks to Its Buy Rating for Aldeyra..
06/8/202206:11EDGARStatement of Changes in Beneficial Ownership (4)
06/8/202206:09EDGARQuarterly Report (10-q)
05/8/202221:06EDGARCurrent Report Filing (8-k)
05/8/202221:00BWAldeyra Therapeutics Reports Second-Quarter 2022 Financial..
05/8/202206:11EDGARStatement of Changes in Beneficial Ownership (4)
04/8/202207:17EDGARStatement of Changes in Beneficial Ownership (4)
Your Recent History
NASDAQ
ALDX
Aldeyra Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230323 14:45:09